Biosintetica

Biosintética is a prominent Brazilian pharmaceutical company specializing in the production of generic and high-complexity medications. Established in 1947 and acquired by Aché Laboratórios Farmacêuticos in 2005, it was the first company to launch a generic drug in Brazil. The company focuses on therapeutic areas such as cardiology, oncology, and the central nervous system, providing a broad portfolio of affordable healthcare solutions. Through its involvement in the Bionovis joint venture, Biosintética is also active in the development and manufacturing of biosimilars. It maintains a strong commercial presence in Latin America, operating as a strategic business unit within the Aché group.